23.9.2004
A comparison between reference intervals suggested by NORIP and by the national societies of clinical chemistry in Norway and Sweden.
# means in column NORIP, plasma: Same as for serum
# means for columns Norway and Sweden: Same as NORIP
Component |
NORIP standard Unit |
Gender |
Age |
NORIP |
NORWAY |
SWEDEN |
|||||
Scandinavian Journal of Clinical and Laboratory Investigation 2004, 64, 271-84 |
Tidsskrift for Norsk Lęgeforening Nr 11, 2004; 124; 1515-7 |
Läkartidningen Nr 10, 2004, vol 101 |
|||||||||
Serum |
Plasma |
Serum |
Serum and plasma |
||||||||
Non enzymes |
Low |
High |
Low |
High |
Low |
High |
Low |
High |
|||
Albumin |
g/L |
FM |
18-39 |
36 |
48 |
# |
# |
# |
|||
40-69 |
45 |
||||||||||
>70 |
34 |
||||||||||
Bilirubin |
umol/L |
FM |
>18 |
5 |
25 |
# |
# |
# |
|||
Calcium |
mmol/L |
FM |
>18 |
2.15 |
2.51 |
# |
# |
2.15 |
2.50 |
||
Calcium, albumin corrected |
mmol/L |
FM |
18-49 |
2.17 |
2.47 |
# |
# |
Not commented |
|||
>50 |
2.53 |
||||||||||
Carbamide (urea) |
mmol/L |
F |
18-49 |
2.6 |
6.4 |
# |
# |
# |
|||
>50 |
3.1 |
7.9 |
|||||||||
M |
18-49 |
3.2 |
8.1 |
# |
|||||||
>50 |
3.5 |
3.5 |
8.2 |
||||||||
Cholesterol |
mmol/L |
FM |
18-29 |
2.9 |
6.1 |
# |
# |
# |
|||
30-49 |
3.3 |
6.9 |
|||||||||
>50 |
3.9 |
7.8 |
|||||||||
Creatininium |
umol/L |
F |
>18 |
50 (451) |
90 |
# |
# |
# |
|||
M |
>18 |
60 |
100 (1051) |
||||||||
Iron |
umol/L |
FM |
>18 |
9 |
34 |
# |
# |
# |
|||
Iron saturation4 |
F |
18-49 |
0.10 |
0.50 |
# |
# |
# |
||||
>50 |
0.15 |
||||||||||
M |
>18 |
0.57 |
0.15 |
0.60 |
|||||||
Glucose |
mmol/L |
FM |
>18 |
4.0 |
6.0 |
4.2 |
6.3 |
# |
# (plasma) |
||
HDL-cholesterol |
mmol/L |
F |
>18 |
1.0 |
2.7 |
# |
# |
# |
|||
M |
>18 |
0.8 |
2.1 |
||||||||
Potassium |
mmol/L |
FM |
>18 |
3.6 |
4.6 |
3.5 |
4.4 |
# |
# (separate for serum and plasma) |
||
LDL-cholesterol |
mmol/L |
FM |
18-29 |
1.2 |
4.3 |
# |
1.32 |
4.3 |
# |
||
30-49 |
1.4 |
4.7 |
1.52 |
4.82 |
|||||||
>50 |
2.0 |
5.3 |
2.0 |
5.42 |
|||||||
Magnesium |
mmol/L |
FM |
>18 |
0.71 |
0.94 |
# |
# |
0.70 |
0.95 |
||
Sodium |
mmol/L |
FM |
>18 |
137 |
145 |
# |
144 |
# |
# |
145 |
|
Phosphate |
mmol/L |
F |
>18 |
0.85 |
1.50 |
0.76 |
1.41 |
# |
0.80 |
1.50 |
|
M |
18-49 |
0.75 |
1.65 |
0.71 |
1.53 |
0.70 |
1.60 |
||||
>50 |
1.35 |
1.23 |
0.75 |
1.40 |
|||||||
Protein |
g/L |
FM |
>18 |
62 |
78 |
64 |
79 |
# |
64 |
79 |
|
TIBC |
umol/L |
FM |
>18 |
49 |
83 |
47 |
80 |
# |
47 |
80 |
|
Triglyceride |
mmol/L |
FM |
>18 |
0.45 |
2.60 |
# |
# |
# |
|||
Urate (uric acid) |
umol/L |
F |
18-49 |
155 |
350 |
# |
# |
# |
|||
>50 |
400 |
||||||||||
M |
>18 |
230 |
480 |
||||||||
Enzymes |
Gender | Age | NORIP, U/L |
Norway, U/L |
Sweden, µkal/L(U/L) |
||||||
Alanine transaminase |
|
F |
>18 |
10 |
45 |
# |
# |
0.15 (9) |
0.75 (45) |
||
M |
>18 |
70 |
1.1 (66) |
||||||||
Aspartate transaminase |
F |
>18 |
15 |
35 |
# |
# |
0.25 (15) |
0.60 (36) |
|||
M |
>18 |
45 |
0.75 (45) |
||||||||
Creatine kinase |
F |
>18 |
35 |
210 |
# |
Not commented |
0.60 (36) |
3.5 (210) |
|||
M |
18-49 |
50 |
400 |
0.80 (48) |
6.7 (402) |
||||||
>50 |
40 |
280 |
0.70 (42) |
4.7 (282) |
|||||||
Alkaline phosphatase |
FM |
>18 |
35 |
105 |
# |
# |
0.60 (36) |
1.8 (108) |
|||
Gamma-Glutamyl-transferase |
F |
18-39 |
10 |
45 |
# |
# |
0.15 (9) |
0.75 (45) |
|||
>40 |
75 |
1.2 (72) |
|||||||||
M |
18-39 |
80 |
1.3 (78) |
||||||||
>40 |
15 |
115 |
0.20 (12) |
1.9 (114) |
|||||||
Amylase |
FM |
>18 |
25 |
120 |
# |
# |
0.40 (24) |
2.0 (120) |
|||
Amylase, pancreatic |
FM |
>18 |
10 |
65 |
# |
# |
0.15 (9) |
1.10 (66) |
|||
Lactate dehydrogenase |
FM |
18-69 |
105 |
205 |
# |
# |
1.8 (108) |
3.4 (204) |
|||
>70 |
115 |
255 |
1.9 (114) |
4.2 (252) |
|||||||
1 Enzymatic methods and Jaffe methods corrected for non-creatinine chromogens (e.g. by measuring a creatinine-free serum)
2 Reference intervals for NORIP originally computed with LDL-chol. = Cholesterol - HDL-chol. - triglycerides/2 while the intervals suggested in Norway is calculated with the formula: LDL-chol. = Cholesterol - HDL-chol. - triglycerides/2.2